MRNA
PUTS ▼Moderna, Inc.
$54.49
-2.36%delayed
News – · Trend ▼ · below put trigger ▼
Expected move (1d)
▼ $50.73to$58.25 ▲
ATR ±$3.76 (+6.90%)Implied ±$4.81 (+8.83%)
Entry Reference
Price / prev close$54.49 / $55.80
Day range$54.16 – $56.23
52-wk range$22.28 – $85.60(51%)
Volume vs avg0.55×
ATR (14d)$3.76
MA 8 / 21$56.78 / $65.93
MA 50 / 200$58.03 / $44.56
Call ▲ / Put ▼ trigger$56.69 / $54.92
+1 / +2 ATR$58.25 / $62.01
-1 / -2 ATR$50.73 / $46.97
Support: 51.90 48.09 47.14
Resistance: 54.68 56.20 59.48
Near-the-money contracts
exp 2026-07-31Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 52 | $4.31 | 151% | 0.69 | -0.57 | 3 |
| 53 | $3.52 | 140% | 0.63 | -0.57 | 14 |
| 54 | $2.73 | 126% | 0.56 | -0.54 | 346 |
| 55 | $2.65 | 146% | 0.48 | -0.63 | 4835 |
| 56 | $2.00 | 134% | 0.40 | -0.56 | 310 |
| 57 | $1.62 | 134% | 0.33 | -0.52 | 612 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 52 | $1.34 | 124% | -0.28 | -0.44 | 364 |
| 53 | $1.60 | 117% | -0.35 | -0.46 | 237 |
| 54 | $2.08 | 118% | -0.44 | -0.50 | 371 |
| 55 | $2.66 | 121% | -0.53 | -0.52 | 366 |
| 56 | $3.13 | 115% | -0.62 | -0.47 | 389 |
| 57 | $3.85 | 119% | -0.69 | -0.44 | 314 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- Moderna Q2 Earnings Loom: Buy or Sell the Stock Ahead of Results?5h ago
- Moderna (MRNA) Stock May Be Overvalued After Cancer Trial Start6h ago
- Moderna Stock Has Doubled in 2026, But Wall Street Still Isn’t Convinced7h ago
- Why Moderna (MRNA) Is Down 6.5% After Europe Clears Its First Flu-COVID Combo Vaccine9h ago
- 3 Biotech Stocks With Massive Upside to Buy Before August Starts10h ago
- 1 Healthcare Stock to Keep an Eye On and 2 We Avoid21h ago
- 2 Major Reasons to Buy Moderna Stock Before July 311d ago
- Q1 Earnings Highlights: Moderna (NASDAQ:MRNA) Vs The Rest Of The Therapeutics Stocks2d ago
- Moderna (MRNA) Laps the Stock Market: Here's Why2d ago
- After Soaring Nearly 90% Thus Far in 2026, Is Moderna's Stock Still a Buy?2d ago
- Therapeutics Stocks Q1 Highlights: Moderna (NASDAQ:MRNA)2d ago
- What Moved Markets This Week5d ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.